Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
COVID, XEC
Hybrid COVID variant XEC is more contagious: What to know about the new strain
The variant, which first appeared in Berlin in late June, has increasingly seen hundreds of cases in Germany, France, Denmark and Netherlands, according to a report by Australia-based data integration specialist Mike Honey.
New XEC COVID variant is on the rise. What are its symptoms, and what states is it in?
The new "XEC" COVID-19 variant spreading rapidly in Europe has arrived in the US. What are the symptoms, will it cause a fall surge, and are vaccines effective? Experts discuss
XEC, the new COVID-19 variant: Is it fatal? Will vaccines work? Here's what doctors want you to know
The contagious nature of the new XEC COVID-19 variant is drawing attention. It has been found in China, Europe, and the United States. It is a hybrid of Omicron subvariants. Vaccines help prevent serious illness even though they may not offer complete protection against infection,
USA Today
2d
New COVID-19 variant making its way to California: What to know about XEC variant
Omicron
variant KP.3.1.1, also known as deFLuQE, made up over half (52.7%) of
COVID
-19 cases between Sept. 1 and Sept. 14 ...
2h
New XEC COVID subvariant poses potential threat heading into winter. Doctors urge vaccinations
The coronavirus subvariant XEC is drawing more attention as a potential threat heading into late autumn and winter — ...
Pharmabiz
10h
EMA’s human medicines committee recommends marketing approval for Pfizer & BioNTech’s Omicron KP.2-adapted Covid-19 vaccine
EMA’s human medicines committee recommends marketing approval for Pfizer & BioNTech’s Omicron KP.2-adapted Covid-19 vaccine: New York Monday, September 23, 2024, 10:00 Hrs [IS ...
3d
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
EuropaWire
2d
Pfizer and BioNTech’s Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive EU Opinion, Awaiting Approval
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...
Pulse
5h
Evidence ‘weak’ for doctors using FFP3 over surgical masks, Covid inquiry hears
The evidence that FFP3 masks were more protective for doctors than surgical masks is ‘weak’, the Covid inquiry has heard.
1d
Fears of fast spread of XEC Covid strain after many haven’t had vaccines in long time
Exclusive: Lower levels of protective antibodies could leave the UK population vulnerable to a rapid spread of the XEC Covid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
XEC
United States
Feedback